Cart
sales@molnova.com
Astrasieversianin VII
CAS No. 86764-11-6
Astrasieversianin VII( —— )
Catalog No. M19198 CAS No. 86764-11-6
Isoastragaloside II is a derivative Astragaloside I, an ingredient in Astragalus membranaceus which is reported to have osteogenic properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 151 | In Stock |
|
| 10MG | 225 | In Stock |
|
| 25MG | 376 | In Stock |
|
| 50MG | 561 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAstrasieversianin VII
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsoastragaloside II is a derivative Astragaloside I, an ingredient in Astragalus membranaceus which is reported to have osteogenic properties.
-
DescriptionIsoastragaloside II is a derivative Astragaloside I, an ingredient in Astragalus membranaceus which is reported to have osteogenic properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number86764-11-6
-
Formula Weight827.01
-
Molecular FormulaC43H70O15
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (60.46 mM)
-
SMILESCC(=O)OC1C(COC(C1O)OC2CCC34CC35CCC6(C(C(CC6(C5CC(C4C2(C)C)OC7C(C(C(C(O7)CO)O)O)O)C)O)C8(CCC(O8)C(C)(C)O)C)C)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cheng, X., et al.: Phytother. Res., 30, 1680-1688 (2016).
molnova catalog
related products
-
Dapivirine
Dapivirine (TMC120) is a non-nucleoside inhibitor for HIV reverse transcriptase with IC50 of 24 nM.
-
Punicalin
Punicalin exerts anti-inflammatory antioxidative and anti-hepatotoxic activities it shows inhibitory activity on HIV-1 reverse transcriptase in a dose-dependent manner with an IC50 of 0.11 microg/ml (0.14 microM).
-
ALW-II-41-27
ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
